Carbon-11 Labeled Sarcosine in Prostate Cancer

Completed

Conditions studied: Prostate Cancer

In brief

Men with and without prostate cancer will have a PET/CT scan that measures the level of the amino acid sarcosine. PET is a scanning method that uses short lived radioactivity.

Key facts

Study ID

NCT02462447

Run by

University of Michigan

People needed

20

Starts

2015-06-01

Expected to finish

2017-02-08

Last updated by the study team

2017-11-09

Who can join

Age: 40 and older. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• Males 40 years of age or older
• Confirmed or suspected prostate cancer and will undergo a planned tissue biopsy of the known or suspected tumor (Prostate Cancer Group 1 only)

You may not qualify if…

• Active malignancy (except basal cell or squamous cell skin cancer) within the last 2 years
• Body weight > 350 lbs (158 kg)
• Prisoners
• Subject not willing or able to sign informed consent

Where it is running

• University of Michigan Health Systems — Ann Arbor, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.